PHARMAKODEX LTD has a total of 58 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and macromolecular chemistry and polymers are SOSEI R&D LTD, ROXRO PHARMA INC and GI COMPANY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 13 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Australia | 6 | |
#5 | United States | 6 | |
#6 | Canada | 4 | |
#7 | New Zealand | 2 | |
#8 | Poland | 2 | |
#9 | Singapore | 2 | |
#10 | Brazil | 1 | |
#11 | China | 1 | |
#12 | Hong Kong | 1 | |
#13 | Israel | 1 | |
#14 | Norway | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Packaging and shipping | |
#5 | Consumer goods |
# | Name | Total Patents |
---|---|---|
#1 | Staniforth John | 28 |
#2 | Staniforth John Nicholas | 12 |
#3 | Goggin Paul | 11 |
#4 | Tobyn Michael John | 9 |
#5 | Tobyn Michael | 6 |
#6 | Simpson David | 3 |
#7 | Talwar Naresh | 3 |
#8 | Hearn Matthew Paul | 2 |
#9 | John Staniforth | 2 |
#10 | Clinch Cheryl | 2 |
Publication | Filing date | Title |
---|---|---|
GB0910559D0 | Packaging receptacle | |
GB0910560D0 | Packaging receptacle | |
GB0823493D0 | Formulations | |
GB0823486D0 | Formulations | |
GB0819981D0 | Packaging receptacle | |
GB0625322D0 | Pharmaceutical compositions | |
WO2007066147A1 | Topical compositions for paediatric use | |
GB0524961D0 | Transdermal administration of active agents for systemic effect | |
GB0524962D0 | Topical pharmaceutical compositions | |
GB0524959D0 | Topical compositions for treatment of respiratory disorders | |
GB0524958D0 | Transdermal administration of active agents | |
GB0501809D0 | Anti-migraine formulations | |
GB0501810D0 | Chemotherapeutic formulations | |
EP1455888A2 | Topical administration device |